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Background: Albizia adianthifolia (Schumach.) W. Wright (Fabaceae) is a traditional herb largely used in the African
traditional medicine as analgesic, purgative, anti-inflammatory, antioxidant, antimicrobial and memory-enhancer
drug. This study was undertaken in order to evaluate the possible cognitive-enhancing and antioxidative effects of
the aqueous extract of A. adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease.
Methods: The effect of the aqueous extract of A. adianthifolia leaves (150 and 300 mg/kg, orally, daily, for 21 days)
on spatial memory performance was assessed using Y-maze and radial arm-maze tasks, as animal models of spatial
memory. Pergolide - induced rotational behavior test was employed to validate unilateral damage to dopamine
nigrostriatal neurons. Also, in vitro antioxidant activity was assessed through the estimation of total flavonoid and
total phenolic contents along with determination of free radical scavenging activity. Statistical analyses were performed
using two-way analysis of variance (ANOVA). Significant differences were determined by Tukey’s post hoc test. F values
for which p < 0.05 were regarded as statistically significant. Pearson’s correlation coefficient and regression analysis were
used in order to evaluate the association between behavioral parameters and net rotations in rotational behavior test.
Results: The 6-OHDA-treated rats exhibited the following: decrease of spontaneous alternations percentage within
Y-maze task and increase of working memory errors and reference memory errors within radial arm maze task.
Administration of the aqueous extract of A. adianthifolia leaves significantly improved these parameters, suggesting
positive effects on spatial memory formation. Also, the aqueous extract of A. adianthifolia leaves showed potent
in vitro antioxidant activity. Furthermore, in vivo evaluation, the aqueous extract of A. adianthifolia leaves attenuated the
contralateral rotational asymmetry observed by pergolide challenge in 6-OHDA-treated rats.
Conclusions: Taken together, our results suggest that the aqueous extract of A. adianthifolia leaves possesses
antioxidant potential and might provide an opportunity for management neurological abnormalities in Parkinson’s
disease conditions.
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Parkinson’s disease (PD), the second most common neu-
rodegenerative disorder after Alzheimer’s disease (AD),
is characterized by motor and behavioral disturbances that
include a resting tremor, postural instability and bradyki-
nesia [1]. PD affects approximately 2% of the population,
although incidence varies across age, gender and race [2].
PD is often complicated by a variety of cognitive symp-
toms that range from isolated memory and thinking prob-
lems to severe dementia. While the motor symptoms
of PD are well-known (tremor, rigidity, slowness of
movement, imbalance), the commonly seen deficits in
memory, attention, problem-solving, and language are less
understood. Studies have shown that over 50% of people
with PD experience some form of cognitive impairment.
About 20% have more substantial cognitive impairment
[3]. Memory problems in PD are typically milder than in
Alzheimer’s disease. In PD, the person may have difficulty
concentrating, learning new information and recalling
names [3]. Non-motor symptoms in advanced stages of PD
such as depression, dementia, sleep abnormalities and auto-
nomic failure are probably the consequence of degeneration
of both dopaminergic and non-dopaminergic systems,
which still lacks efficacious treatments at present [4].
Although the etiology of the neurodegenerative pro-
cesses found in PD is not completely understood, it is
suggested that a state of oxidative imbalance is triggered
by one or more factors, among which are brain aging,
genetic predisposition, mitochondrial dysfunction, free
radical production and environmental toxins [5-8].
Neuropathological evidence from both human and
experimental models of PD firmly supports a significant
role for oxidative stress in the death of dopaminergic (DA)
neurons in the substantia nigra (SN) [9]. Although no
model to date has been able to recapitulate all the
pathological features of PD, the genetic or neurotoxic
animal models of PD have contributed much to our
understanding of human PD [10,11]. Neurotoxins-based
models of PD have a long history and represent the most
important models while genetic animal models have failed
to recapitulate the key neurobehavioral or pathological
features of PD [10,11].
6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) and rotenone, are
the most successful agents so far to mimic parkinsonism
in vitro and in vivo. 6-OHDA is taken up by the dopamine
transporter (DAT) and it then generates free radicals [12].
Extensive study of these models has defined important
cellular actors of cell death including oxidative stress,
mitochondrial dysfunction, excitotoxicity, neuroinflamma-
tion and nitric oxide which is presumably critical of the
nigral degeneration [13,14]. Furthermore, the neurotoxic
models can serve as valuable tools for the assessment of
efficacy and side-effects of symptomatic treatments of PDand have offered a basis for the development of novel
therapeutic strategies [15].
Discovery of new drugs from traditional medicine is
not a new phenomenon. Current researches are focusing
on finding therapies, preferentially from natural products
which could help in preventing/delaying the ongoing
neurodegeneration in PD [16,17]. Research confirms that
several medicinal herbs-based extracts increase redox/
antioxidative abilities of the body and can effectively
slow the progression of PD [3,17,18].
Among the plants used in traditional medicine, Albizia
adianthifolia (Schumach.) W. Wright (Fabaceae) is com-
monly used in Cameroon as a remedy. In fact, it grows
in most African countries. Its use in traditional medicine
varies from one country to another. The sap is applied
on the eye to treat river blindness and conjunctivitis,
used as decoction, leaves treat respiratory diseases and
have analgesic proprieties. An infusion or decoction of
the bark is used to treat scabies and other skin diseases.
A decoction of the leaves is administered as a purgative,
as an analgesic and against inflammation. In Central and
West Africa, this plant is used for the treatment of skin
diseases, bronchitis, tapeworm, headaches and sinusitis
[19,20].
Aqueous and ethanol extracts of A. adianthifolia
(Schumach.) W. Wright (stem bark) used in southern
Africa to treat memory loss and Alzheimer’s disease,
have been screened for acetylcholinesterase inhibitory
activity [21]. The root ethanolic extract of this plant
showed in vitro immunomodulatory activity on the Jurkart
T cell [22]. Kim et al. [23] reported that the aqueous
extract of A. julibrissin had anxiolytic-like effects in
rats as assessed using the elevated plus-maze test. Also, a
recent study indicated that julibroside C1 extracted from
A. julibrissin stem bark produced potent anxiolytic-like
effects in mice [24]. Aurantiamide acetate was the most
active compound isolated from the stem bark of A.
adianthifolia through antioxidant activity (DPPH) and
trolox equivalent antioxidant capacity (TEAC) assays
were used to detect the antioxidant activity EC50
values 9.51 μg/ml and 78.81 μg/ml, respectively. The bark
extracts of A. lebbeck possess free radical scavenging activity
against 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and
reducing power assays. Their results on DPPH free radical
scavenging at 1000 μg/ml indicated maximum antioxidant
activity of 91.82% and 90.08%, respectively. Ethanolic
extract of A. procera showed strong scavenging activity
against free radicals compared to various standards. These
in-vitro assays indicate that these plant extracts are a good
source of natural antioxidants, which might be helpful in
preventing the progress of various oxidative stresses [25],
with relevance for Parkinson’s disease conditions.
Despite extensive knowledge about the effects of Albizia
species extracts, there is no study clarifying the possible
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adianthifolia leaves extract in animal models of PD.
In this way, the present study aims to investigate the
possible antioxidant activity and behavioral recovery
following chronic administration of the aqueous extract
of A. adianthifolia leaves using a unilateral 6-OHDA-
lesion rat model of PD.
Methods
Plant material and plant extract
Albizia adianthifolia leaves were collected in Elounden,
near Yaoundé (Cameroon) in June 2010 and identified by
Dr. Nolé Tsabang at the National Herbarium Yaoundé
where a voucher specimen (N° HNC 29997) was registered
and deposited for ready reference. A. adianthifolia leaves
were air dried and pulverized into fine powder. Five
hundred grams of pulverized sample material was macer-
ated in 5 L of distilled water for 48 h at room temperature
and then the mixture was filtered through Whatman filter
paper no. 3. The aqueous extract was then lyophilized
to obtain powder used for our various tests. The dried
extract was dissolved in distilled water and adminis-
tered by gastric gavage to animals at the doses of 150
and 300 mg/kg body weight.
HPLC (LC/DAD) analysis
To identify the main compounds of the aqueous extract
of A. adianthifolia leaves an Agilent 1200 HPLC system
(Agilent Technologies, Palo Alto, CA, USA) and photo-
diode array detector (DAD) coupled with an analytical
workstation were used. The working conditions are: Agi-
lent Zorbax Eclipse XDB-C18 column (4.6 × 150 mm,
5 μm); column temperature: 40°C; detection wavelength:
203, 254, 282, 326 and 521 nm; flow rate: 1 mL/min;
gradient elution: acetonitrile (solvent A) and water (solvent
B); the initial conditions were 2% A and 98% B; the linear
gradient programme was of 2-14-20-30-25% solvent A
at 0-20-40-50-60 min, after which we switched back to the
initial conditions; sample injection (20 μL) was performed
by an autosampler programme. As standards we used
caffeic, chlorogenic, ferulic, and rosmarinic acids, the
flavonoids: apigenin, apigenin 7-O-glucoside, hyperoside,
luteolin, luteolin 7-O-glucoside, rutin and quercetin
(LG Standards). To generate the calibration curve, the
standard stock solutions were diluted with methanol
and analyzed in the same conditions. HPLC data revealed
that among flavonoids, only apigenin was identified and
quantified. Nevertheless, the levels of flavonoid com-
pounds taken separately were low, this being the main
characteristic of the sample (Figure 1).
Animals
40 male Wistar rats weighing 350 ± 50 g at the start of
the experiment were used. The animals were housed ina temperature and light-controlled room (22°C, a 12-h
cycle starting at 08:00 h) and were fed and allowed to
drink water ad libitum. Rats were treated in accordance
with the guidelines of animal bioethics from the Act on
Animal Experimentation and Animal Health and Welfare
from Romania and all procedures were in compliance with
Directive 2010/63/EU of the European Parliament and
of the Council of 22 September 2010 on the protection
of animals used for scientific purposes. This study was
approved by the Ethics Committee of Alexandru Ioan
Cuza University of Iasi, Romania and also, efforts were
made to minimize animal suffering and to reduce the
number of animal used.
In vitro experimental test
Estimation of total flavonoid content
The aluminum chloride colorimetric method was modi-
fied from the previous procedure reported [26]. A 0.01%
rutoside solution was used to make the calibration curve.
5 mL of the methanol extract solution (3 g lyophilized
powder/100 g solution) was mixed with 3 mL of 2.5%
aluminum chloride and 17 mL of methanol. After incuba-
tion at room temperature for 45 min, the absorbance of
the reaction mixture was measured at 430 nm using a
Shimadzu UV-1700 spectrophotometer. The amount of
2.5% aluminum chloride was substituted by the same
amount of methanol in blank. The total flavonoid content
was expressed as mg rutoside per gram of lyophilized
powder. Each assay was repeated trice and the results,
recorded as mean of the triplicated experiments.
Estimation of total phenolic content
The total phenolic content of the lyophilized powder
was determined by the Folin-Ciocalteu reagent [27]
with modifications. The calibration curve was prepared
using a 0.1% gallic acid solution. 40 μL extract solution
(30 mg/ml) was mixed with 3160 μL of distilled water
and 200 μL of Folin-Ciocalteu reagent. After 5 min,
600 μL of 20% sodium carbonate solution was mixed. The
mixture was kept for incubation at room temperature for
2 h and the absorbance was measured at 765 nm using a
Shimadzu UV-1700 spectrophotometer. The total phen-
olic content was expressed as mg gallic acid per gram of
lyophilized powder. Each assay was repeated trice and the
results, recorded as mean of the triplicated experiments.
Determination of free radical scavenging activity
The free radical scavenging activity of the lyophilized
powder was determined using the stable radical DPPH
(2,4-dinitrophenyl-1-picryl hydrazyl) method as previously
described [28]. 200 μL of the tested sample were placed in
test tubes and 2 mL of freshly prepared DPPH solution
(60 μM) in methanol was added in each test tube and
mixed. 30 min later, the absorbance was measured at
Figure 1 HPLC data for apigenin isolated from the the aqueous extract of A. adianthifolia leaves.
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capability to scavenge the DPPH radical was calculated,
using the following equation:
DPPH scavenged %ð Þ ¼ Ac−Atð Þ=Ac½   100
Where Ac is the absorbance of the control reaction and
At is the absorbance in presence of the plant samples.
For the antioxidant activity determination we used a
3 mg/mL methanol extract solution. Each assay was




All surgical procedures were conducted under aseptic
conditions, under sodium pentobarbital (50 mg/kg
b.w., i.p., Sigma-Aldrich, Germany) anesthesia. Rats were
mounted in the stereotaxic apparatus with the nose
oriented 11° below horizontal zero plane. Thereafter, the
animals received a right-unilaterally intranigral injections
of 5 μL of 0.9% saline containing 2.5 μg/ μL 6-OHDA (free
base) and 0.2% ascorbic acid (w/v) at a rate of 1 μL/min at
the following coordinates: 5.5 mm posterior to bregma;
2.0 mm lateral to the midline; 7.4 mm ventral to the
surface of the cortex, according to the stereotaxic atlas
[29]. All rats sustaining 6-OHDA lesion were pretreated
with desipramine (25 mg/kg, i.p. in saline) 30 min before
anesthesia in order to protect noradrenergic system. The
rats in the control group (sham-operated) were given
5 μL of 0.9% saline - 0.2% ascorbic acid administered in
a similar manner as the solution containing 6-OHDA.Drug administration
The rats were divided into 4 groups (10 per group): (1)
control group (sham-operated received distilled water
treatment); (2) 6-OHDA-lesioned group, as negative
control, received distilled water treatment; (3) 6-OHDA-
lesioned group received 150 mg/kg of the aqueous ex-
tract of A. adianthifolia leaves treatment (6-OHDA +AE
(150 mg/kg)); and (4) 6-OHDA-lesioned group received
300 mg/kg of the aqueous extract of A. adianthifolia
leaves treatment (6-OHDA + AE (300 mg/kg)). The
administration of the distilled water and the aqueous
extract was performed by gastric gavage with biomedical
needles (length 7.62 cm, ball diameter 4 mm, straight).
The volume administered was 10 ml/kg of body weight,
daily, for 21 consecutive days after neurosurgery.
Rotational behavior
The animals were tested for rotational behavior by pergo-
lide (0.5 mg/kg, b.w., s.c., Sigma-Aldrich, Germany) 1 week
after the 6-OHDA injection. The drug pergolide functions
as a dopamine receptor agonist for D2 and D1 receptors
and as a ligand to serotonin 5-HT1A, 5-HT1B, 5-HT2A, 5-
HT2B, and 5-HT2C receptors [30,31]. Also, it was argued
that pergolide induced contralateral rotation in animals
with striatal lesion after systemic administration [32].
Briefly, 1 min after pergolide injection, full rotations were
counted in a cylindrical container (a diameter of 33 cm
and a height of 35 cm) at 10 min intervals for 60 min
in a quiet isolated room. Rotations in the ipsilateral and
contralateral directions were counted separately and
the analyses were based on the net scores (contralateral
minus ipsilateral rotations) recorded for 60 min [33].
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Short-term memory was assessed by spontaneous alter-
nation behavior in the Y-maze task. The Y-maze used in
the present study consisted of three arms (35 cm long,
25 cm high and 10 cm wide) and an equilateral triangular
central area. 30 min after the aqueous extract of A.
adianthifolia leaves administration, rats were placed at
the end of one arm and allowed to move freely through
the maze for 8 min. An arm entry was counted when
the hind paws of the rat were completely within the
arm. Spontaneous alternation behavior was defined as
entry into all three arms on consecutive choices. The
number of maximum spontaneous alternation behaviors
was then the total number of arms entered minus 2 and
percent spontaneous alternation was calculated as (actual
alternations/maximum alternations) × 100. The maze was
cleaned with a 10% ethanol solution and dried with a
cloth before the next animal was tested. Spontaneous
alternation behavior is considered to reflect spatial working
memory, which is a form of short-term memory [34,35].
Radial 8 arm-maze task
The radial 8 arm-maze used in the present study con-
sisted of 8 arms, numbered from 1 to 8 (48 × 12 cm),
extending radially from a central area (32 cm in diameter).
The apparatus was placed 40 cm above the floor, and
surrounded by various extramaze visual cues placed at
the same position during the study. At the end of each
arm there was a food cup that had a single 50 mg food
pellet. Prior to the performance of the maze task, the
animals were kept on restricted diet and body weight
was maintained at 85% of their free-feeding weight over
a week period, with water being available ad libitum.
Before the actual training began, three or four rats were
simultaneously placed in the radial maze and allowed
to explore for 5 minutes and take food freely. The food
was initially available throughout the maze, but was
gradually restricted to the food cup. The animals were
trained for 4 days to run to the end of the arms and
consume the bait. To evaluate basal activity of rats in
radial 8 arm-maze, the rats were given 1 training trial
per day to run to the end of the arms and consume the
bait. The training trial continued until all the 5 baits
had been consumed or until 5 minutes has elapsed.
After adaptation, all rats were trained with 1 trial per
day. Briefly, 30 min after the aqueous extract of A.
adianthifolia leaves administration, each animal was placed
individually in the center of the maze and subjected to
working and reference memory tasks, in which same 5
arms (no. 1, 2, 4, 5 and 7), were baited for each daily
training trial. The other 3 arms (no. 3, 6 and 8) were
never baited. An arm entry was counted when all four
limbs of the rat were within an arm. Measures were
made of the number of working memory errors (enteringan arm containing food, but previously entered), reference
memory errors (entering an arm that was not baited).
The maze was cleaned with a 10% ethanol solution and
dried with a cloth before the next animal was tested.
Reference memory is regarded as a long-term memory
for information that remains constant over repeated
trials (memory for the positions of baited arms), whereas
working memory is considered a short-time memory in
which the information to be remembered changes in every
trial (memory for the positions of arms that had already
been visited in each trial) [35,36].
Histological control
At the end of the experiment, all animals were killed with
overdose of sodium pentobarbital (100 mg/kg b.w. i.p.,
Sigma-Aldrich, Germany) followed by the transcardial
infusion of 0.9% saline and a 10% formalin solution.
The brain were removed and placed in a 30% sucrose/
formalin solution. The brain were frozen and cut into
coronal sections (50 μm) using a freezing microtome
and stained with crezyl violet for verification of the
point of the syringe needle. Only experimental data from
lesions correctly located in the substantia nigra (SN) were
used for statistical analysis.
Statistical analysis
The animal’s behavioral activities in Y-maze and radial
8 arm-maze tasks were statistically analyzed by two-way
analysis of variance (ANOVA) using XLSTAT version
2012. 1.01 software, Addinsoft. In the spontaneous al-
ternation experiments within Y-maze task, one sample
t-test was used for comparison of the alternation to
chance level (50%). In order to evaluate differences be-
tween groups in radial arm-maze task, separate
repeated-measures ANOVA were calculated on number
of working memory errors and number of reference
memory errors with group (Control, 6-OHDA, 6-
OHDA + AE (150 mg/kg) and (6-OHDA + AE (300 mg/
kg)) as between-subject factor and days (1 to 7) as
within-subjects factors. All results are expressed as mean
± S.E.M. F values for which p < 0.05 were regarded as sta-
tistically significant. Significant differences were deter-
mined by Tukey’s post hoc test. Pearson’s correlation
coefficient and regression analysis were used in order to
evaluate the association between behavioral parameters
and net rotations in rotational behavior test.
Results
Histological verification
After 6-OHDA-lesions, the rats recovered quickly and
gained weight by first week. In the majority of SN-lesioned
rats the point of the syringe needle was positioned in
the central part of the SN and the lesions extended to a
Figure 2 Protective effects of the aqueous extract of A.
adianthifolia leaves (150 and 300 mg/kg) on pergolide (0.5 mg/kg,
b.w., s.c.)-induced rotational behavior in 6-OHDA-lesioned rats.
1 week after 6-OHDA injection, the number of net rotation contralateral
to the lesion side was increased. However, the administration of the
aqueous extract of A. adianthifolia leaves restored the decrease in the
number of net rotation. Values are means ± S.E.M. (n = 10 animals per
group), **p < 0.001, ***p < 0.0001 vs. 6-OHDA alone treated-group.
Beppe et al. BMC Complementary and Alternative Medicine 2014, 14:142 Page 6 of 11
http://www.biomedcentral.com/1472-6882/14/142part of adjacent structures including substantia nigra
pars reticulata, without any significant damage.
Total flavonoids, total phenolic content and free
radical-scavenging capacity of the A. adianthifolia leaves
The methanol extracts of the tested A. adianthifolia leaves
exhibited high content of phenols and high radical scaven-
ging property (DPPH scavenged %). Additionally, A.
adianthifolia leaves present low level of the flavonoids.
The results strongly suggest that phenolics and flavonoids
are important components of the A. adianthifolia leaves
and this could explain their high radical scavenging activity
(Table 1).
Effect pergolide on rotational behavior
Pergolide-induced rotational behavior was analyzed to
assess the unilateral degeneration of the dopamine nigros-
triatal neurons. Control group did not show any significant
any significant bias in turning behavior after receiving
pergolide injection. In contrast, rats exhibited contralateral
rotational behavior following pergolide challenge in 1 week
after the unilateral administration of 6-OHDA into the
substantia nigra. In the rotational behavioral test, ANOVA
revealed an attenuation of asymmetric motor behavior
(F(3,36) = 20.03, p < 0.0001) in experimental animals treated
with the aqueous extract of A. adianthifolia leaves (150 and
300 mg/kg) in a dose-dependent manner as compared
to control group (Figure 2). Additionally, Tukey’s post
hoc analysis revealed a significant difference between
the control and 6-OHDA groups (p < 0.0001), control and
6-OHDA+AE (150 mg/kg) groups (p < 0.0001), control
and 6-OHDA + AE (300 mg/kg) groups (p < 0.0001),
6-OHDA and 6-OHDA + AE (150 mg/kg) groups
(p < 0.001), 6-OHDA and 6-OHDA + AE (300 mg/kg)
groups (p < 0.0001) and 6-OHDA + AE (150 mg/kg)
and 6-OHDA + AE (300 mg/kg) groups (p < 0.0001)
(Figure 2).
Effect of A. adianthifolia extract on spatial memory in
Y-maze task
In the Y-maze task, ANOVA revealed a significant increase
of spatial memory performance in 6-OHDA-lesioned
groups treated with low-and high-doses (150 and
300 mg/kg) of the aqueous extract of A. adianthifolia
leaves (F(3,36) = 8.21, p < 0.001) (Figure 3B), indicated by
an increase of the spontaneous alternation percentage
compared to 6-OHDA alone-treated group, suggestingTable 1 Total flavonoids, total phenolic content and free-scav
leaves
Phenols
(mg gallic acid/g lyophilized pow
Albizia adianthifolia leaves extract 30.172 ± 0.863significant effects on short-term memory. Additionally,
Tukey’s post hoc analysis revealed a significant difference
between the control and 6-OHDA groups (p < 0.0001),
control and 6-OHDA+AE (150 mg/kg) groups (p < 0.0001),
6-OHDA and 6-OHDA + AE (150 mg/kg) groups (p <
0.0001) and 6-OHDA and 6-OHDA + AE (300 mg/kg)
groups (p < 0.001), indicating that the aqueous extract
significantly improved spatial working memory (Figure 3B).
Furthermore, spontaneous alternation percentage in con-
trol (t = 8.86, p = 0.001), 6-OHDA (t = 14.63, p = 0.001),
6-OHDA and 6-OHDA + AE (150 mg/kg) (t = 61.93,
p = 0.0001) and 6-OHDA and 6-OHDA +AE (300 mg/kg)
(t = 4.32, p = 0.05) groups were statistically different from
the chance level (50%) (Figure 3B).
The changes in the spontaneous alternation percentage
of both 6-OHDA and 6-OHDA + AE (150 mg/kg) and
6-OHDA and 6-OHDA + AE (300 mg/kg) groups are
not related to the changes in locomotor activity, asenging capacity of the extract of Albizia adianthifolia
Flavonoids DPPH
der) (mg rutoside/g lyophilized powder) scavenged%
0.525 ± 0.001 58.189 ± 0.601
Figure 3 Effects of the aqueous extract of A. adianthifolia leaves (150 and 300 mg/kg) on spontaneous alternations% (B) and number of
arm entries (A) in the 6-OHDA-treated rats. Values are means ± S.E.M. (n = 10 animals per group), **p < 0.001 vs. 6-OHDA alone treated-group.
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Effect of A. adianthifolia extract on spatial memory in
radial 8 arm-maze task
To investigate whether the aqueous extract of A. adianthi-
folia leaves (150 and 300 mg/kg) affects spatial memory
formation, the rats were further evaluated in the radial
arm-maze task.
For working memory errors, repeated-measures ANOVA
revealed non-significant effects of time-group interaction
(F(12,91) = 0.679, p > 0.05) (Figure 4A). Additionally, Tukey’s
post hoc analysis revealed significant differences between
the control and 6-OHDA groups (p < 0.001), 6-OHDA
and 6-OHDA+AE (150 mg/kg) groups (p < 0.001) and 6-
OHDA and 6-OHDA+AE (300 mg/kg) groups (p < 0.001)
for working memory errors (Figure 4A), indicating that
the aqueous extract of A. adianthifolia leaves significantlyFigure 4 Effects of the aqueous extract of A. adianthifolia leaves (150
reference memory errors (B) during 7 days training in radial arm-mazimproved working memory during 7 days training in radial
arm-maze task.
For reference memory errors, repeated-measures ANOVA
revealed a significant time difference (F(6,91) = 4.957,
p < 0.0001) (Figure 4B). Additionally, Tukey’s post hoc
analysis revealed significant differences between the
control and 6-OHDA groups (p < 0.01), control and 6-
OHDA +AE (150 mg/kg) groups (p < 0.01) and 6-OHDA
and 6-OHDA + AE (300 mg/kg) groups (p < 0.05) for
reference memory errors (Figure 4B), indicating that the
aqueous extract of A. adianthifolia leaves significantly
improved long-term memory during 7 days training in
radial arm-maze task.
More importantly, when linear regression was deter-
mined, a significant correlation between the percentages of
spontaneous alternation vs. net rotation (n = 40, r = −0.723,
p < 0.0001) (Figure 5A), working memory errors vs. net
rotation (n = 40, r = 0.497, p < 0.001) (Figure 5B) andand 300 mg/kg) on the working memory errors (A) and the
e task. Values are means ± S.E.M. (n = 10 animals per group).
Figure 5 Correlation between the percentages of spontaneous alternation vs. net rotation (A), working memory errors vs. net rotation
(B) and reference memory errors vs. net rotation (C) in control group (▲), 6-OHDA alone treated group (■), 6-OHDA + AE (150 mg/kg)
group (●) and 6-OHDA + AE (300 mg/kg) group (♦).
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p < 0.01) (Figure 5C) was evidenced.
Discussion
In recent years, much attention has been focused on
the protective biochemical function of naturally present
antioxidants in biological systems, and on the mechanisms
of their action [37]. A. adianthifolia (Schumach.) W.
Wright (Fabaceae) is used in Central and West Africa
for the treatment of skin diseases, bronchitis, inflamed
eyes, tapeworm, headaches and sinusitis [19,20]. The roots
of A. adianthifolia are used for improving memory in
Venda Region, Southern Africa [38]. However, the scien-
tific bases of the use of this plant have not yet clearly
established. The antioxidant and neuroprotective activity
of this herb extract was determined in the present study.
Phenolic and nitrogenous compounds are known to be
potent antioxidants due to their ability to scavenge free
radicals and active oxygen species such as singlet oxygen,
superoxide anion radical and hydroxyl radicals [39-41].
Our results showed that A. adianthifolia extract pos-
sesses high contents of phenols. The presence of suchcompounds could be responsible for the strongest in vitro
antioxidant activity found in the aqueous extract of A.
adianthifolia leaves. Theses observed in vitro activities
suggest that this plant extract could exert protective
effects also in vivo against oxidative and free radical
injuries occurring in different pathological conditions,
including neurodegenerative diseases.
It is well known that the substantia nigra is the area of
the brain that is most affected in PD but other brain
areas are also affected. The hippocampus is the brain area
that plays an important role in spatial memory [42,43],
therefore we determined the cognitive performance of rats
using the Y-maze and radial arm-maze tests, as animal
models of spatial memory. Moreover, it is well known that
hippocampal formation is involved in learning and mem-
ory, and it was reported that the hippocampus plays an
important role in processing, and remembering spatial
and contextual information [44].
Intranigral injection of the 6-OHDA interferes with
memory function subsequently causes impairment of
spatial memory within the Y-maze and radial arm-maze
tasks, in accordance with previous investigation using
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OHDA-lesion rat model was used to determinate the
behavioral recovery following 7 days of the aqueous
extract of A. adianthifolia leaves administration.
The pergolide results confirm the impairment of the
dopaminergic system. It has been shown that the dentate
gyrus of the hippocampus received the dopaminergic
projection from the ventral tegmental area (A10) and the
substantia nigra (A9) [46]. The dopaminergic connection
to the hippocampus might be affected leading to cognitive
deficits observed in the 6-OHDA-treated rats. Further-
more, our results suggest that the antioxidant activity of
the aqueous extract of A. adianthifolia leaves contributed
to observed spatial memory improvements.
In the present study we used two well-characterized
hippocampus-dependent spatial memory tasks: Y-maze
and radial arm-maze. Our results showed that the aque-
ous extract of A. adianthifolia leaves sustain memory
formation in the 6- OHDA-lesion rodent model of PD.
The HPLC analysis determined that among flavones,
the main component is apigenin, so this is probably
the constituent responsible for the observed cognitive-
enhancing effects in the 6-OHDA-lesion rodent model
of PD. It is suggested that apigenin and related com-
pounds stimulate adult neurogenesis in vivo and in vitro,
by promoting neuronal differentiation and also promotes
learning and memory performance in the Morris water
task [47].
The Y-maze task is a specific and sensitive test of spatial
recognition memory in rodents. The test relies on an innate
tendency of rats to explore a novel environment [48]. The
Y-maze used in this study involves no aversive stimuli
and was considered suitable for evaluating memory. The
specific part of the brain involved in the performance of
this task include the hippocampus [49].
As shown in Figure 3, the aqueous extract of A.
adianthifolia leaves (150 and 300 mg/kg) in 6-OHDA-
treated rats, but especially the low dose (150 mg/kg),
significantly improved short-term memory, as evidenced
by the percentage of spontaneous alternation as compared
to 6-OHDA alone-treated rats. This result suggests that
both doses of the aqueous extract of A. adianthifolia
leaves used in this study display an improved effect on
acquisition of the short-term memory of the 6-OHDA-
treated rats within the Y-maze task. However, no differences
were observed between both doses of the aqueous extract
of A. adianthifolia leaves on spatial working memory in the
Y-maze task. Also, the aqueous extract of A. adianthifolia
leaves increased both the locomotor activity as well as
short-term memory in 6-OHDA-treated rats within the
Y-maze task. This effect of the aqueous extract observed
in short-term memory cannot be attributed exclusively
to increase locomotor activity, because the percentage
of spontaneous alternation was also improved and theeffect of improving working and reference memory is
also observed in radial arm-maze task. Therefore, the
improvement of short-term memory observed in 6-OHDA
rats treated with the aqueous extract is not an artifact due
to the concomitant increase in motor activity.
In the behavioral neuroscience trial, radial 8 arm-maze
(RAM) task is widely used [35,50]. These RAM tests are
useful in evaluating the effect of drugs, stress and various
other environmental factors on learning and memory [51].
Working memory and reference memory are the two
variables that report the physiological status of the brain
[51]. Thus, 6-OHDA rats treated with the aqueous extract
(150 and 300 mg/kg) exhibited an improvement of work-
ing memory (Figure 4A) as compared to 6-OHDA alone-
treated rats, during 7 days training in radial arm-maze
task. On the other hand, both doses of the aqueous extract
(150 and 300 mg/kg) significantly improved long-term
memory of 6-OHDA-treated rats, explored by reference
memory (Figure 4B) as compared to 6-OHDA alone-treated
rats, during 7 days training in radial arm-maze task. These
findings could suggest that the aqueous extract plays an
important role in spatial memory formation, especially on
working and reference memories. However, no significant
differences were observed between both doses of the
aqueous extract on working memory and reference
memory in radial arm-maze task.
Moreover, we found a significant positive correlation
between the percentages of spontaneous alternation vs.
net rotation, working memory errors vs. net rotation and
reference memory errors vs. net rotation when linear
regression was determined. These results could suggest
that increase of behavioral parameters in the Y-maze
and radial arm-maze tasks along with the decrease of the
contralateral rotational asymmetry observed by pergolide
challenge in 6-OHDA-treated rats could be related to
involvement of the aqueous extract of A. adianthifolia
leaves in neuroprotection against 6-OHDA-induced contra-
lateral rotational behavior following pergolide challenge.
Regarding the limitation of our study we can add that
there is an indirect behavioral evidence (e.g. rotational
behavior) that the lesion worked rather than neurochem-
istry of the striatum to confirm the size of lesion.Conclusions
In summary, this study demonstrated that the aqueous
extract of A. adianthifolia leaves exerts memory-enhancing
effects in the 6-OHDA-lesion rodent model of PD via its
antioxidant effects. Consequently, the use of this aqueous
extract as an adjuvant therapeutic agent for the treatment
of the cognitive impairment in PD should be considered.Competing interest
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